Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life prospective study

BACKGROUND: Clinical studies on the effectiveness of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are scarce in China. Moreover, identifying potential biomarkers predicting its efficacy remains a great challenge. METHODS: In this prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ming, Sima, Yutong, Liu, Chengyao, Zhao, Jinming, Shao, Shan, Wang, Xinmao, Wang, Yue, Cao, Feifei, Xiong, Wei, Wang, Xiangdong, Zhang, Luo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519616/
https://www.ncbi.nlm.nih.gov/pubmed/36254182
http://dx.doi.org/10.1016/j.waojou.2022.100702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519616/
https://www.ncbi.nlm.nih.gov/pubmed/36254182
http://dx.doi.org/10.1016/j.waojou.2022.100702

Ejemplares similares